Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Brunet

Showing results (261-270 of 492) with videos related to

Pageof 50
Sort By:
Bone Marrow Transplantation|August 26, 1998
Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|July 1, 1996
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish GroupA Urbano-Ispizua, C Solano, S Brunet, et al.
Annals of Hematology|February 17, 2020
Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies)E Bussaglia, M Pratcorona, M Carricondo, et al.
Bone Marrow Transplantation|October 3, 1998
Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Leukemia|January 6, 2007
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early interventionJ Esteve, L Escoda, G Martín, et al.
Blood|January 12, 2001
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblingsA Urbano-Ispizua, C Rozman, P Pimentel, et al.
Leukemia|April 16, 2013
Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AMLJ F Nomdedéu, M Hoyos, M Carricondo, et al.
Journal of the National Cancer Institute|May 30, 1998
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genesJ S Brunet, P Ghadirian, T R Rebbeck, et al.
Bone Marrow Transplantation|October 12, 1999
Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBTJ de la Rubia, C Martínez, C Solano, et al.
Sangre|April 1, 1997
[Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group]S Brunet, A Urbano-Ispizua, C Solano, et al.
Pageof 50

Showing results (261-270 of 492) with videos related to

Sort By:
Pageof 50
Bone Marrow Transplantation|August 26, 1998
Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|July 1, 1996
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish GroupA Urbano-Ispizua, C Solano, S Brunet, et al.
Annals of Hematology|February 17, 2020
Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies)E Bussaglia, M Pratcorona, M Carricondo, et al.
Bone Marrow Transplantation|October 3, 1998
Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Leukemia|January 6, 2007
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early interventionJ Esteve, L Escoda, G Martín, et al.
Blood|January 12, 2001
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblingsA Urbano-Ispizua, C Rozman, P Pimentel, et al.
Leukemia|April 16, 2013
Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AMLJ F Nomdedéu, M Hoyos, M Carricondo, et al.
Journal of the National Cancer Institute|May 30, 1998
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genesJ S Brunet, P Ghadirian, T R Rebbeck, et al.
Bone Marrow Transplantation|October 12, 1999
Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBTJ de la Rubia, C Martínez, C Solano, et al.
Sangre|April 1, 1997
[Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group]S Brunet, A Urbano-Ispizua, C Solano, et al.
Pageof 50